text:
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.
Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).
Chronic lymphocytic leukemia (also called CLL) is a blood and bone marrow disease that usually gets worse slowly. CLL is the second most common type of leukemia in adults. It often occurs during or after middle age; it rarely occurs in children.
Normally, the body makes blood stem cells (immature cells) that become mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell.
A myeloid stem cell becomes one of three types of mature blood cells:
A lymphoid stem cell becomes a lymphoblast cell and then one of three types of lymphocytes (white blood cells):
Blood cell development. A blood stem cell goes through several steps to become a red blood cell, platelet, or white blood cell.
In CLL, too many blood stem cells become abnormal lymphocytes and do not become healthy white blood cells. The abnormal lymphocytes may also be called leukemia cells. The lymphocytes are not able to fight infection very well. Also, as the number of lymphocytes increases in the blood and bone marrow, there is less room for healthy white blood cells, red blood cells, and platelets. This may cause infection, anemia, and easy bleeding.
This summary is about chronic lymphocytic leukemia. See the following PDQ summaries for more information about leukemia:
Older age can affect the risk of developing chronic lymphocytic leukemia.
Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for CLL include the following:
Possible signs of chronic lymphocytic leukemia include swollen lymph nodes and tiredness.
Usually CLL does not cause any symptoms and is found during a routine blood test. Sometimes symptoms occur that may be caused by CLL or by other conditions. Check with your doctor if you have any of the following problems:
Tests that examine the blood, bone marrow, and lymph nodes are used to detect (find) and diagnose chronic lymphocytic leukemia.
The following tests and procedures may be used:
Certain factors affect treatment options and prognosis (chance of recovery).
Treatment options depend on:
The prognosis (chance of recovery) depends on:
After chronic lymphocytic leukemia has been diagnosed, tests are done to find out how far the cancer has spread in the blood and bone marrow.
Staging is the process used to find out how far the cancer has spread. It is important to know the stage of the disease in order to plan the best treatment. The following tests may be used in the staging process:
There are three ways that cancer spreads in the body.
When cancer cells spread outside the blood, a solid tumor may form. This process is called metastasis. The three ways that cancer cells spread in the body are:
The new (metastatic) tumor is the same type of cancer as the primary cancer. For example, if leukemia cells spread to the brain, the cancer cells in the brain are actually leukemia cells. The disease is metastatic leukemia, not brain cancer.
The following stages are used for chronic lymphocytic leukemia:
Stage 0
In stage 0 chronic lymphocytic leukemia, there are too many lymphocytes in the blood, but there are no other symptoms of leukemia. Stage 0 chronic lymphocytic leukemia is indolent (slow-growing).
Stage I
In stage I chronic lymphocytic leukemia, there are too many lymphocytes in the blood and the lymph nodes are larger than normal.
Stage II
In stage II chronic lymphocytic leukemia, there are too many lymphocytes in the blood, the liver or spleen is larger than normal, and the lymph nodes may be larger than normal.
Stage III
In stage III chronic lymphocytic leukemia, there are too many lymphocytes in the blood and there are too few red blood cells. The lymph nodes, liver, or spleen may be larger than normal.
Stage IV
In stage IV chronic lymphocytic leukemia, there are too many lymphocytes in the blood and too few platelets. The lymph nodes, liver, or spleen may be larger than normal and there may be too few red blood cells.
Refractory chronic lymphocytic leukemia is cancer that does not get better with treatment.
There are different types of treatment for patients with chronic lymphocytic leukemia.
Different types of treatment are available for patients with chronic lymphocytic leukemia. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Five types of standard treatment are used:
Watchful waiting
Watchful waiting is closely monitoring a patient's condition without giving any treatment until symptoms appear or change. This is also called observation. During this time, problems caused by the disease, such as infection, are treated.
Radiation therapy
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The way the radiation therapy is given depends on the type and stage of the cancer being treated.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, or the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.
See Drugs Approved for Chronic Lymphocytic Leukemia for more information.
Splenectomy is surgery to remove the spleen.
Targeted therapy
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Monoclonal antibody therapy is a type of targeted therapy used in the treatment of chronic lymphocytic leukemia.
Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances in the body that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.
New types of treatment are being tested in clinical trials.
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI Web site.
Chemotherapy with stem cell transplant
Chemotherapy with stem cell transplant is a method of giving chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.
Biologic therapy
Biologic therapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.
Patients may want to think about taking part in a clinical trial.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Follow-up tests may be needed.
Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests. This is sometimes called re-staging.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Stage 0 Chronic Lymphocytic Leukemia
Treatment of stage 0 chronic lymphocytic leukemia is usually watchful waiting.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage 0 chronic lymphocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Stage I, Stage II, Stage III, and Stage IV Chronic Lymphocytic Leukemia
Treatment of stage I, stage II, stage III, and stage IV chronic lymphocytic leukemia may include the following:
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage I chronic lymphocytic leukemia, stage II chronic lymphocytic leukemia, stage III chronic lymphocytic leukemia and stage IV chronic lymphocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
Treatment of refractory chronic lymphocytic leukemia may include the following:
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with refractory chronic lymphocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.
For more information from the National Cancer Institute about chronic lymphocytic leukemia, see the following:
For general cancer information and other resources from the National Cancer Institute, see the following:
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Changes were made to this summary to match those made to the health professional version.
Call 1-800-4-CANCER
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.
Chat online
The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
Write to us
For more information from the NCI, please write to this address:
Search the NCI Web site
The NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families. For a quick search, use the search box in the upper right corner of each Web page. The results for a wide range of search terms will include a list of "Best Bets," editorially chosen Web pages that are most closely related to the search term entered.
There are also many other places to get materials and information about cancer treatment and services. Hospitals in your area may have information about local and regional agencies that have information on finances, getting to and from treatment, receiving care at home, and dealing with problems related to cancer treatment.
Find Publications
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237).
PDQ is a comprehensive cancer database available on NCI's Web site.
PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ is available online at NCI's Web site. PDQ is provided as a service of the NCI. The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research.
PDQ contains cancer information summaries.
The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries are available in two versions. The health professional versions provide detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions provide current and accurate cancer information.
Images in the PDQ summaries are used with permission of the author(s), artist, and/or publisher for use within the PDQ summaries only. Permission to use images outside the context of PDQ information must be obtained from the owner(s) and cannot be granted by the National Cancer Institute. Information about using the illustrations in the PDQ summaries, along with many other cancer-related images, are available in Visuals Online, a collection of over 2,000 scientific images.
The PDQ cancer information summaries are developed by cancer experts and reviewed regularly.
Editorial Boards made up of experts in oncology and related specialties are responsible for writing and maintaining the cancer information summaries. The summaries are reviewed regularly and changes are made as new information becomes available. The date on each summary ("Date Last Modified") indicates the time of the most recent change.
PDQ also contains information on clinical trials.
A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Listings of clinical trials are included in PDQ and are available online at NCI's Web site. Descriptions of the trials are available in health professional and patient versions. Many cancer doctors who take part in clinical trials are also listed in PDQ. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
Last Revised: 2012-11-21
If you want to know more about cancer and how it is treated, or if you wish to know about clinical trials for your type of cancer, you can call the NCI's Cancer Information Service at 1-800-422-6237, toll free. A trained information specialist can talk with you and answer your questions.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

subset: commoncrawl


text:
Step 1.
Pre-heat oven to 220℃ in 'Fan Mode'.
Step 2.
In a lightly-heated pan, add vegetable oil and fry the onions for a bit till they soften.
Step 3.
Add thyme and butter to the pot - allow the butter to melt.
Step 4.
Add Emmenthal Cheese and whipping cream. Next, mix all the ingredients together till they have melted.
Step 5.
Stir the liquid gradually and consistently as it thickens into a smooth, thick and creamy consistency.
Step 6.
Add boiled pasta to the mixture after taking the sauce off the heat. Season the pasta and sauce with pepper and salt to your preferred taste.
Step 7.
Pour the pasta and sauce into the cored pumpkin, scatter it with Parmesan cheese and bake it for 30 minutes till the pasta turns gold and bubbles can be seen.
Step 8.
Garnish with freshly cracked black pepper, parsley and extra virgin olive oil.
Recommended Product
Versatile and convenient kitchen assistant
Handblenders are not only compact, simple to use and easy to clean, they also come with multiple accessories for chopping and blending – making them great for quick and convenient food preparation.


text:
When you see rosaries for sale online you will notice that the beads are typically measured in millimeters. Here is America we aren't too familiar with the metric system so the difference between 4mm and 10mm may not mean much to us. To help, we have created this rosary sizing guide so you can determine what bead size is best for you.
3mm beads are the smallest beads you will usually find on a rosary. These beads are very delicate and frequently seen on children's rosaries and rosary bracelets.
6mm – 8mm beads are the "standard" size beads you see for rosaries. Beads in this size range are sometimes carved or faceted.
9mm and larger beads are the perfect size to get for someone who likes carrying a substantial rosary or has arthritis.
20mm and larger beads are typically the size used for wall rosaries.
You can download a printable rosary bead size chart we created with all the different sizes of beads in their actual sizes so you can compare.


text:
1. When a motion filed under K.S.A. 60-1507 is voluntarily dismissed after a successful appeal and remand for a full evidentiary hearing, a sentencing court is not required to entertain a second motion for similar relief unless exceptional circumstances are shown.
2. Exceptional circumstances are unusual events or intervening changes in the law which prevent a movant from reasonably being able to raise all of the trial errors in the first post-conviction proceeding.
3. An unlawful sentence may be corrected at any time.
Appeal from Sedgwick District Court; PAUL W. CLARK, judge. Opinion filed September 4, 1998. Affirmed.
Debra J. Wilson, assistant appellate defender, and Jessica R. Kunen, chief appellate defender, for appellant.
Elizabeth Rogers, assistant district attorney, Nola Foulston, district attorney, and Carla J. Stovall, attorney general, for appellee.
Before LEWIS, P.J., GREEN and KNUDSON, JJ.
KNUDSON, J.: Mikel Sherman Brooks appeals the summary denial of his pro se motion under K.S.A. 60-1507 attacking the underlying conviction and sentence imposed. We conclude its use constitutes an abuse of process and affirm the district court.
On December 9, 1988, Brooks pled guilty to aggravated robbery and was sentenced to an indefinite term of 6 to 20 years. On June 16, 1989, the district court entered an order nunc pro tunc, providing that Brooks' sentence was to be served consecutive to a sentence imposed in an earlier case.
Brooks filed his first K.S.A. 60-1507 motion on January 3, 1991, contending that he had been denied effective assistance of counsel. The district court summarily denied the motion. On appeal, this court reversed and remanded for an evidentiary hearing on the merits. After the mandate of the Court of Appeals was issued on January 26, 1993, Brooks, with the advice of counsel, dismissed his motion for relief. According to the journal entry of dismissal, Brooks conferred with his attorney as to the "advantages and disadvantages of pursuing the motion for relief pursuant to K.S.A. 60-1507 and [made] a voluntary and informed decision that it would not be beneficial to proceed with the motion . . . ."
In 1994 and 1995, Brooks filed numerous motions and pleadings regarding his conviction and the sentence imposed. Although not well documented in the record on appeal, the State contends in its brief that Brooks filed two more K.S.A. 60-1507 motions concerning the underlying criminal case that were denied by the district court.
K.S.A. 60-1507(c) states: "The sentencing court shall not be required to entertain a second or successive motion for similar relief on behalf of the same prisoner."
Brooks had full opportunity to raise any and all appropriate issues attacking the conviction and sentence in the first 60-1507 proceeding that he voluntarily dismissed after a successful appeal to this court and a mandate that required a full evidentiary hearing. Under these circumstances, K.S.A. 60-1507(c) is applicable. See State v. Foulk, 195 Kan. 349, 351, 404 P.2d 961 (1965).
We next consider whether Brooks has shown exceptional circumstances that would warrant consideration of a successive 60-1507 motion. In Dunlap v. State, 221 Kan. 268, 270, 559 P.2d 788 (1977), the Supreme Court explained:
"Exceptional circumstances as required to justify entertaining a second or successive motion are those unusual events or intervening changes in the law which prevented the movant from being aware of and raising all of his alleged trial errors in his first post-conviction proceeding, and they must be such that the ends of justice can only be served by reaching the merits of the subsequent application. (Hacker v. State, 207 Kan. 195, 483 P.2d 484 [1971].) Unless exceptional circumstances are shown the sentencing court may properly dismiss a second or successive motion filed under K.S.A. 60-1507 on the ground its use constitutes an abuse of remedy. (K.S.A. 60-1507[c]; Lee v. State, 207 Kan. 185, 483 P.2d 482 [1971]. See also Salinger v. Loisel, 265 U.S. 224, 68 L. Ed. 989, 44 S. Ct. 519 [1924], and Wong Doo v. United States, 265 U.S. 239, 68 L. Ed. 999, 44 S. Ct. 524 [1924].)"
The issues Brooks now raises could reasonably have been addressed 7 years ago in his first 60-1507 proceeding. Brooks has failed to show there have been any unusual events or intervening changes in the law that would constitute exceptional circumstances precluding dismissal under K.S.A. 60-1507(c). We conclude the district court did not err in its dismissal of Brooks' 60-1507 petition.
Brooks' final contention is that the district court imposed an illegal sentence under the nunc pro tunc journal entry. He relies upon the holding in State v. Royse, 252 Kan. 394, Syl. ¶ 4, 845 P.2d 44 (1993), which states: "Once a sentence is imposed, the district court is powerless to vacate that sentence and impose a harsher sentence."
Brooks misses the point. The sentence first imposed by the district court was contrary to K.S.A. 1987 Supp. 21-4608(3), which required consecutive sentences. Because the district court initially imposed an unlawful sentence, it had the power and the duty to subsequently correct its error and impose a lawful sentence. See State v. Kerley, 236 Kan. 863, 865, 696 P.2d 975 (1985).


text:
Chrome for Android Beta Channel
Chrome 25 on Android brings a slew of updates and improvements over our current Chrome 18 based stable channel, including better HTML5 support and JavaScript performance. That said, non-Stable channel releases can sometimes be bumpy, and our new Beta release is no exception. The following are some of the larger known issues in today's release:
- Performance is sluggish, noticeably on Galaxy Nexus and Nexus S
- Frequent freeze on devices with specific versions of Qualcomm GPU driver
- Text autosizing may break formatting on some sites
- 164632 - Editing bookmark feature is broken
- 165244 - Text position handler jumps or disappears when moving
- 163439 - Clicking on links in yahoo.com not navigating on Nexus 7
- 166233 - Unable to submit comments on Facebook posts in desktop version of Facebook
- 165244 - Text handler jumps or disappears when moving
- 167351 - Youtube video controls are lost after returning from fullscreen video mode
- 162486 - iframe scrolling broken
Much like other Chrome channels, we'll be pushing regular updates, and we recommend you check the "Auto-update apps" checkbox in Google Play Store settings on your device to get the latest updates right away. If you find a new issue, please let us know by filing a bug. More information on Chrome for Android is available on the Chrome site.
Jason Kersey
Google Chrome
Labels: Chrome Beta for Android


text:
Politics & Government
Auto bailout bill clears House but faces roadblock in Senate
WASHINGTON — The House of Representatives late Wednesday passed by a 237 to 170 vote a $14 billion emergency plan to aid Detroit's ailing auto industry -- but Senate Republicans' doubts about the package put its ultimate fate in serious jeopardy.
The bill's funds could flow quickly to General Motors and Chrysler, which otherwise would face bankruptcy. The measure also would create a "car czar," who'd be appointed by the president to dole out the money, and require the companies to restructure themselves to achieve long-term viability.
The bill, said House Speaker Nancy Pelosi, D-Calif., in her closing argument Wednesday, is "not a life support to sustain a dying industry, but a jumpstart for an industry that is essential to our nation's economy."
The measure passed with bipartisan support, but in the Senate, most Republicans — as well as some Democrats — voiced a long list of concerns, headed by worry that their constituents are reluctant to provide taxpayer money to help GM, Chrysler and Ford. Ford officials have said they don't need help immediately.
Sen. David Vitter, R-La., noted that the measure would require the companies to submit a restructuring plan by March 31. Why not demand that plan before the money is lent, he asked.
"I think the average American would say, 'What?' Isn't that putting the cart before the horse?" Vitter asked. "Isn't that, to use a common phrase, just ass backwards?"
Many supporters conceded that they were uneasy about the plan — a point they made to Democratic leaders in a closed-door caucus — but publicly said they had little choice.
"Much more needs to be done," Pelosi said.
"It's not that I'm enthusiastic about bailing out anybody else," said Rep. Mel Watt, D-N.C., "but the consequences of not doing something could be more severe than doing it."
The bill faces enormous problems in the Senate, where 60 votes are needed to stop procedural delays threatened by the measure's foes. On Wednesday Vice President Dick Cheney and White House Chief of Staff Joshua Bolten met privately for more than an hour with Republican senators, and according to senators present, they heard a barrage of criticism — and offered few satisfying answers.
Senators wanted assurances that the government will be tough on car companies that do not recover swiftly once the loans are made, as well as guarantees that taxpayers will not lose billions. And some suggested bankruptcy could be a preferable alternative."The car czar doesn't have enough authority," said Sen. Robert Bennett, R-Utah. "He needs the authority to create a de facto structured bankruptcy, not consulting and calling meetings."
In addition, said Sen. John Cornyn, R-Texas, "we're worried about the American taxpayer" and whether the money will ever be repaid.
Supporters countered that the bill has strong safeguards against blank checks.
The loans are "a bridge to either fundamental restructuring or bankruptcy," said Joel Kaplan, the deputy White House chief of staff for policy.
The lawmakers' continuing concerns were a surprise because the Bush administration thought it had eased their chief objections when it won key concessions Tuesday from Democrats.
Senate Republican Leader Mitch McConnell of Kentucky wouldn't predict whether he could get enough Republicans to join the lame-duck Senate's 49 Democrats and two independents, most of whom are expected to back the legislation.
"What I think you can pretty safely conclude," he said, "(is) that a matter of this consequence is likely to require 60 votes."
The White House had shared GOP senators' concerns that without precise restructuring guidelines, carmakers would return to Washington next year for more aid.
Kaplan insisted at a White House news briefing that the legislative language was toughened to say that the firms must earn profits as they continued doing business. He called that definition of attaining financial viability "firm." And, he said, if the companies don't come up with restructuring plans that make them viable, "the government gets its money back."
In that scenario, the companies presumably would declare bankruptcy, go out of business or come up with another plan. "If there is no plan that satisfies the conditions for long-term viability," Kaplan said, "there is an explicit prohibition put in the legislation against any federal financing being used to help these firms avoid bankruptcy or to achieve financial viability."
Republicans also wanted to eliminate a provision from the Democratic draft that would have required the automakers to drop lawsuits challenging emissions limits in California and elsewhere, and Democrats agreed.
Negotiators also agreed on the car czar's clout. While President George W. Bush would appoint the official, Kaplan said he'd work closely with President-elect Barack Obama on the choice.
Kaplan said the czar would have the power to force deals with unions, management and suppliers. "This is not somebody who is going to run the companies. This is someone who is going to bring them around the table, knock heads."
None of that swayed the reluctant Republicans.
"Giving Detroit and labor unions billions in taxpayer dollars without serious changes in their business practices is like giving an irresponsible teenager a credit card," said Rep. Steve King, R-Iowa.
New polls show Americans divided over whether the government should help the car companies. A Dec. 6-8 Los Angeles Times/Bloomberg survey found 47 percent said the government should rescue the automakers, while 42 percent said it shouldn't.
CNN/Opinion Research Corp. poll on auto bailout
'Car czar'? Auto-crat would be more like it, some critics say
Business dead, car dealers say they deserve help, too
Big Three auto bailout would put U.S. in driver's seat
Pelosi says Congress won't let Big 3 carmakers go bankrupt


text:
Magenta Flitter ** 6g
Write a review
| Ask a question
Nail art Flitter is fine strips of glitter measuring approx. 2.5mm by 0.4mm, It's available in 2g and 6g pots, which can be mixed into your pot to UV Nail Gel and Clear or Coloured Acrylic Powder to create a custom blend unique to you. Only want enough to create a single design? You can pick up your glitter with a tiny bead of acrylic or gel and apply it straight on to the nail, then cap it with clear or blush pink acrylic powder.


text:
Mens Jewellery
Discover an exquisite range of antique men's jewellery including vintage rings, cufflinks and tie pins at Harrington & Co our stunning collection of internationally-sourced men's jewellery is always evolving as we search for fresh antique finds from all corners of the globe. Whether you're looking for a vintage wedding ring, classic cufflinks, a statement piece or a gift, our rotating range provides something for all occasions.
Each of our pieces is individually valuated by an expert to ensure absolute authenticity. We make sure the style, cut, clarity, colour, weight and any stones are one hundred percent authentic so you can be completely confident in your purchase. We further guarantee that all brands that come through the store are high-end brands that produced premium quality pieces in their respective eras.
We also stock an extensive range of genuine Rolex watches and parts, luxury vintage watches and parts as well as women's Estate Jewellery including earrings, pendants, necklaces and brooches.
Buy or Sell Vintage Men's Jewellery
Do you have vintage men's jewellery pieces gathering dust in your home? Convert them to cash! Harrington and Co is always buying quality goods. We have been recognised as trusted buyers and sellers of antique items for more than 13 years and we guarantee fair prices for both buyers and sellers.


text:
share:Remind Me
TCMDb Archive MaterialsView all archives (0)
DVDs from TCM Shop
The Desert Rats A desperate band of Allied... MORE > $11.21 Regularly $14.98 Buy Now
powered by AFI
DVDs from TCM Shop
The Desert Rats
A desperate band of Allied...
Regularly $14.98 buy now
Brief Synopsis
A desperate band of Allied soldiers fights off the Nazis in North Africa.
In mid-Apr 1941, during World War II, Germany's Afrika Korps, led by Field Marshal Erwin Rommel, has repeatedly beaten the Allies in the struggle for control of North Africa. Desperate to prevent Rommel from gaining control of the Suez Canal, the British Army, in retreat and trying to rebuild its strength, establishes one last stronghold in Tobruk. The British headquarters in Cairo orders the 9th Australian Division to hold Tobruk for two months, at which time they will be relieved. The general meets with artillery colonel Barney White and other officers to explain that the division will have three perimeters of defense: the outlying perimeter of infantry, the second perimeter of White's artillery, and the inner line of fortifications. The general, needing an experienced field officer to oversee the green Australian troops assigned to the infantry perimeter, chooses English officer Capt. Tammy MacRoberts. MacRoberts, a coolly efficient and unemotional officer who is disliked by the Australians, is surprised to see among their ranks his former schoolmaster, Tom Bartlett. As the battalion marches to their desert outpost, they are hit by artillery, and the men resent being pushed on by MacRoberts instead of being allowed to tend to their fallen comrades. At their encampment, Barlett, an alcholic, explains to MacRoberts that after being dismissed from his job in England due to his drinking, he went to Australia and joined the Army while intoxicated. MacRoberts offers to obtain a transfer for the older man, whom he still calls "sir," but Bartlett insists on staying to prove that he is not a coward. During the day, the men dig foxholes and prepare for an upcoming attack by Rommel's tanks, which the general hopes will be annihilated by White's artillery. During a sandstorm, it appears that the tanks will not enter the perimeter where the general predicted, but at the last minute, they change course and head directly over MacRoberts' covered men. The German infantry follows the tanks and engages the Australians in a fierce battle, during which one of their officers, Capt. Currie, is wounded. Lt. Harry Carstairs abandons his vital post to retrieve Currie, although too late to save his life, and after the Germans retreat, an infuriated MacRoberts vows to have Carstairs court-martialed for disobeying orders. Although Sgt. Blue Smith tries to defend MacRoberts, who is now the company's commander, other soldiers grumble that he got Currie killed and should not be so hard on Carstairs. Bartlett then discusses Carstairs with MacRoberts and pleads for leniency, but MacRoberts insists that he cannot allow sentiment to interfere, otherwise he will not be an effective leader. When MacRoberts goes to headquarters, however, he asks the general to tear up the court-martial request, and both he and Carstairs receive field promotions. The general then outlines a plan to erode the Germans' confidence by making small commando raids every night. Even though their casualties are high, as May and Jun pass, MacRoberts' commando patrols exact a toll on the German offensives. One day, after learning the location of a German underground ammunition dump, the general suspects that Rommel may be planning another big push, but the dump is too far away to be attacked during a single nighttime raid. Deciding to use captured Italian trucks as camouflage, the general asks for a company to volunteer, and MacRoberts, knowing his men are sick of two months of being shelled, volunteers them. MacRoberts, who has made Bartlett his clerk in order to protect him, refuses his request to accompany the patrol, then sets out with three trucks loaded with men. During the attack on the German camp, the men fight fiercely and succeed in wiring a bomb to the dump, but before it can be detonated, the soldier in charge is killed. Both MacRoberts and Carstairs leap off their departing truck to detonate the charge, but Carstairs does not survive the blast. The wounded MacRoberts is captured, and while he is being examined in a medical tent, Rommel, who has also been wounded, enters. Although he is respectful of Rommel's superior rank, MacRoberts defiantly states that he will never control the Suez without first capturing Tobruk, which the Allies have held against all odds. Rommel is bemused by the younger man's brashness and orders that he be treated well. Later, as the prisoners are being transported, their trucks are attacked, and MacRoberts and Smith, who was also captured, escape. After an exhausting walk through the desert, the pair reaches camp and joins the fight again. Although Tobruk has been subjected to prolonged attacks by the Luftwaffe and Rommel's artillery and infantry, the Australians, now nicknamed "the desert rats" for their tenacity and foxholes, have held the town for eight months rather than the originally ordered two months. In November, the general tells his officers that the relief column, led by Gen. Claude Auchinleck is headed for Tobruk, and that they need a company to hold a key location, the Ed Duda hill, which overlooks the road on which Auchinleck is traveling. The general assigns MacRoberts' men, ordering them to hold the hill for three days, and as they march, the men grumble about MacRoberts "volunteering" them for another dangerous assignment. Although the men learn that they were chosen because they have become the best-trained and most efficient company in Tobruk, the knowledge is little comfort as the three days stretch into nine. On the morning of the ninth day, fearing that the men can take no more, MacRoberts orders a retreat, although Bartlett begs him to ask the men to stick with it until Auchinleck arrives. The men refuse to leave, despite MacRoberts' orders, and Bartlett proves his own dedication by taking the dangerous forward gunner's position. Just as the Germans begin what would be a deadly assault, the Australians hear bagpipes announcing the arrival of Auchinleck's troops. After a hard-won 242 days, the Allies have held Tobruk and broken Rommel's hold on North Africa.
Cast & Crew
Additional Details
|MPAA Ratings:
|Premiere Info:
|Los Angeles opening: 6 May 1953; New York opening: 8 May 1953
|Release Date:
|Production Date:
|Black and White
|Distributions Co:
|Twentieth Century-Fox Film Corp.
|Mono (Western Electric Sound System)
|Production Co:
|Twentieth Century-Fox Film Corp.
|United States
Leonard Maltin Ratings & Review
User Ratings & Review
This title has not been reviewed. Be the FIRST to write a review by CLICKING HERE >
User Ratings & Review
User Reviews:
Cinema History:
Lead Performers:
Supporting Cast:
Screen Play:
Music Score:
Title Sequence:
User Ratings:
The Desert Nats
Larry (Lawrence) Welk 2017-03-07
Another victory for those plucky good guy Brits & Aussies over those bad guy Germans- their same kind but of another breed! Yawn. At least the boozey... MORE>
desert rats
kevin sellers 2017-03-05
Ok war pic. Wonder who was the bigger alkie, Newton or Burton? There's no question who the better actor was. MORE>


text:
At long last, there is good news for Blackberry fans! After quite a few anxious months, when the very fate of the organization appeared to be in question, RIM CEO Thorsten Heins, announced last week that "there's nothing wrong with the company as it exists right now." What a relief! After all, when you are down 95% in market valuation, you can sort of sense that at some point, if things get worse, questions regarding leadership's prowess will eventually be raised. Fortunately, that won't be necessary, as Mr. Heins also reassured us that "This company is really in the middle of a transition. We know what we're doing; we're executing on our programs." Whew! It could have been really close had management not responded in time with this announcement. Now we know that there's no "death spiral" in RIM's future, although the notion of "free fall" does come to mind. How did this happen? How could a great company, with a great brand, and a great product, be victimized so quickly? Were they ambushed? Did they never see it coming?
The answer, my friends, is that this was not sudden at all. In fact, RIM's slow slide into ignominy has been going on for a rather long-time, as did Kodak's and Nokia's, and the railroads, and fax machines, and the decline of physical mail, as well. The one thing that that all these now "disrupted" organizations had in common was the sloooooowness of how their declines played-out. All too often, disruption is not so much about surprise, as it is about slowprise!
What accounts for slowprise? To a very large extent, the chief culprit is success. Our past success, and a desire to enjoy the associated rewards to the full, lead many firms into denial and sluggishness in the face of needing to adjust to a potential disruptive offering from somewhere else; particularly if we don't take that "somewhere else" very seriously. SONY's reluctance to move away from its once-great Trinitron technology, at a time when everybody else saw that the future was flat-panel TVs, is a case in point. Imagine how difficult it was for RIM to confront the reality of the smart phone challenge in the face of rising revenues and profits, which had been the case over the past several years – with revenues and profits actually peaking in 2011 -- until, suddenly it seems too late! But, the point is that RIM's demise was anything but "sudden." And, management missed it. As did, Kodak's, and Nokia's, and so many others.
Another culprit that makes slooowprise so deadly is leadership overconfidence, or hubris; the belief that we know what we're doing, despite everyone else starting to do something different, can be a killer. Isn't that what RIM's Mr. Heins said: "We know what we're doing"? After all, we're "leaders," we must be good! We made it to the top, so we must know what we're doing to get to such positions! Yet, Disney's inability to take computer-animation seriously, at a time when Pixar was experimenting with what would become the industry's next big breakthrough, was likely the result of leadership overconfidence -- in a set of technologies that were fast fading from the scene. Similarly, RIM's inability to appreciate what was going on around it as smartphones emerged, is also an example of what has been referred to as "blinding confidence" in the company's C-suite. The "imperial" assumption by many Western entrants into the Chinese market that "only an experienced Western manager was suitable to run a Chinese operation" provides yet another aspect of how "managerial overconfidence" can derail even the best planned strategic alternatives.
The role of leadership confidence turns out to be a complex phenomena. My good friend and IMD colleague Phil Rosenzweig tells me that there is a very strong stream of thought in contemporary management literature revealing overconfidence as a pernicious threat to sound managerial strategic choice, despite its desirability in those instances where we need to inspire employees to take an organization beyond what even they think is possible in the pursuit of a new advantage. And, even in those situations where managerial confidence is a necessary prerequisite for big change initiatives, you need to ensure is that such confidence does not distort the ability of leadership to accurately read the strategic battlefield that the firm is competing on. RIM certainly needs confident leaders at this point in time, but do I really believe that they are looking soberly at the situation at present? Not from Mr. Heins's recent comments! In fact, it appears to me that his view of the future is pocked-marked with "blindspots."
An inability to take threats seriously, or to look far enough outside of the familiar in order to see emerging challenges, frequently leads to firms falling afoul of strategic "blind spots", which are essentially traps for the unwary. Estelle Metayer, a "blindspot spotter", who has worked with me in IMD programs aimed at reducing such myopia, has suggested that HP's appointment of Léo Apotheker, who lacked essential experience outside of software, set HP up for falling into just such blindspots when it came to hardware.
The bottom line of all of this, of course, is that disruption is a failure of leadership more than innovation. It is all-too-often neither rapid, nor unexpected, but slow and tortuous. We all watched in horror as Kodak died a death of thousand tiny cuts, and we all watched in mystification and could not imagine what was taking RIM, or Nokia, so long to wake-up? In every case, well-intentioned, experienced and well-meaning leaders let their organizations down. Perhaps, disruption is less about urgency and more about awareness -- the need to watch different communities and to try to look further-out into the future; less about responsiveness and more about pro-sponsiveness-- trying more to be the disrupter, or to try to imagine what a disrupter might be thinking, rather than being able to respond quickly, but after the event? If strategy is all about choice, then the way that the C-suite regards the future, and the transitory nature of any competitive advantage, may be one of the biggest choices of all.
Bill Fischer is the co-author (with Andy Boynton & Bill Bole) of The Idea Hunter (Jossey-Bass, 2011).
Bill Fischer can be followed on Twitter at @bill_fischer


text:
Review Overview
Responsive & Browsers Compatibility
User Friendly
Custom Options
Social Features
SEO Features
Pendulum is an Elegant and latest template. It is perfect for DJs, producers, musicians, music clubs. Easy to use and userfriendly. The template helps you to create modern portfolio.
Awesome Features
Admin Panel
R-panel is a very powerful template management system. Ability to easily and quickly customize according to your needs, and – best of all – you don't need advanced skills to use it! It is also not branded – you don't have to worry that someone will notice that you are using our system.
Ability to change your CSS style or add Javascript code using our R-panel, additionally system will highlight code syntax. Don't worry – the code will stay untouched after upgrading the theme.
Not quite familiar with CSS? You can use Color Picker or Background Manager and system will generate proper code itself – it's easy and fun!
In our R-Panel you have also easy access to Cufon and Google Web font's libraries that makes over 400 fonts which you can use in your theme. Create as many sidebars as you need! You don't have to stay with just one or two sidebars for all your pages and posts anymore. You are now able to create multiple sidebars with just few clicks.
With R-panel built in option you will never miss any theme upgrade – if your theme is out of date you'll be automatically informed and prompted to download the latest version.
Shortcodes Manager
Now you have an easy way to put shortcodes in your content. Click on the blue button in your WordPress editor – you will see a pop-up window with a list of available shortcodes. Select shortcode that you want to put in the text and press "insert" button. That's all! Now selected shortcode will appear in your text. It's THAT easy!
Powerful Intro
With this feature you can make every page of your site even more original and eye catching! Add Sliders, 3D sliders, Youtube movies, Vimeo movies and many more to every single page of your template – every page can have different options embedded.
It's that easy: choose intro type, set parameters and enjoy!
Full localization
All of Rascals Labs themes are Internationalized (I18n). You can easily translate them to your own language
Detailed documentation with step by step Video Tutorials
To learn how to use our template is very simple with our complete video guide. Additionally, the template contains instructions in HTML format full of useful information.
Cross-browser compatibility
Our main goal was to create a template layout which is highly compatible with almost all the browsers like Internet Explorer, Firefox, Safari, Opera, Chrome etc. Cross browser compatibility and W3C validation of our themes are crucial in the successful running of the website.
Complete list of features
Cufon Font Replacement and Cufon fonts Manager.
350+ Fonts Available (Cufon and Google Fonts).
Unlimited Colors.
Background Generator – Simple way to create a different background for each page, post…etc.
MP3 player compatible with Mobile Devices (iPod, iPhone…)
Background Generator – Simple way to create a different background for each page, post…etc.
Unique jQuery Slider:
Supports: Images, Videos, Music (Vimeo, YouTube).
Custom links.
Drag drop ajax sorter.
3 Custom posts types:
Portfolio (drag drop ajax sorter).
Slider (drag drop ajax sorter).
Events manager.
5 Color styles.
5 Custom widgets:
R-Cat – Displays the blog categories.
R-Posts – Displays latest blog posts with thumbnails.
Twitter – Displays latest tweets.
R-Flickr – Displays photos from flickr.
R-Comments – Displays recents comments.
Drag Drop Slider Manager.
Managing layout has never been so easy: just choose and use!
XML demo content for fast setup.
Custom style shortcodes with Shortcodes Manager.
Unlimited sidebars.
Complete set of Instructional Training Videos.
Various Portfolio Content types (video, swf, quicktime, images, vimeo, youtube, custom lightbox content).
Full localization – template and administrative interface.
Supports image, video or swf for portfolio items.
Gorgeous jQuery Enhancements.
Unlimited blog pages.
Powerful Administration Panel.
HTML5 and CSS3.
Multi level dropdown menu (R-Menu).
Wide pages and posts.
Cross browser compatible.
Many back-end options to customize the theme.
Tableless coding.
Clean, well-commented, and organized code and files.
Built in full working AJAX contact form (without page refreshing and setup in admin panel).
Layered and sliced PSD Files Included.
Server requirements
WordPress 3.3
MySQL 5 or higher
PHP 5 or higher
URL library support (compiled into to PHP)
GD 2 library support


text:
This is an attempt to make Morroblivion contemporary to events of Oblivion, by removing various time inconsistances.
Made for Morroblivion 061, should work with 062.
Changes are:
- restored original chargen (start in jail)
- removed all cliff racers. {{BASH:Delev}} added.
- disabled Jiub
- disabled Caius Cosades
- made morrowind topics work ok (little secret etc)
- disabled ability to join Great Houses
- restored Oblivion's starting timestamp
- disabled Maiq
- disabled all quests which would give same artifacts as in Oblivion
- disabled Tribunal MQ.
- added 2 spells to travel to/from Mournhold, sold in MG in Balmora
- added 70 oblivion gates all over Vvardenfell and Solstheim
- Ald'ruhn is now overrun with daedra.
- disabled the door to Dagoth Ur
- disabled Fargoth, removed his ring.
V 1.01 update:
- disabled Gothren, his Mouth and Bolvyn Venim
v 1.02 update:
- Reduced daedra count at Ald-ruhn to 10 (not counting those who emerge from gates) to lessen the impact on AI
- added price to corprus meat ingredients. Wicked stuff - but goot for preparing poisons.
V 1.03 update
- added a quest which has a script adding all those topics and closing MW chargen quest. Now this mod should be compatible with alternative start (in Tamriel) mod.
V 1.05 is posted below.
V 1.06 is posted below.
V 1.07 is posted below.
Mod is designed to be used with a new game.
Load order: put it along with other Morroblivion-enhancing mods.
Have fun.


text:
Politics & Government
Obama v. Limbaugh: Poll finds it's no contest
WASHINGTON — The deepening recession is taking a slight toll on President Barack Obama's standing, but he's still twice as popular as archnemesis Rush Limbaugh, according to a new McClatchy-Ipsos poll.
The survey found that 65 percent of Americans approve of the way Obama is doing his job roughly 50 days into his presidency. That was down slightly from 69 percent a month ago.
At the same time, 29 percent disapprove of Obama's performance, a small increase from 26 percent a month ago. The poll of 1,070 adults taken last Thursday through Monday has an error margin of plus or minus 3 percentage points.
Still, the president's numbers remain high, roughly twice as high as his predecessor's in his final year in office and more than twice as high as those for Limbaugh, the right-wing radio talk-show host.
The poll found 30 percent of Americans with favorable opinions of Limbaugh, and 46 percent with unfavorable opinions. A solid 33 percent of all Americans have "very unfavorable" opinions of the talk show host.
The numbers help explain why Obama and his team relish a pitched battle with Limbaugh, a polarizing figure who's enormously popular with his fans but deeply unpopular with even more people.
The White House jumped on Limbaugh after he said that he wanted the president to fail in achieving his agenda. The White House was trying to force other Republicans either to stand with the controversial Limbaugh at the risk of alienating other Americans or to rebuke him, angering his listeners and him.
The most prominent victim was Republican National Committee Chairman Michael Steele, who criticized Limbaugh, then apologized.
As partisan lines harden over Obama's agenda and presidency, Democrats and Republicans tend to see the economy and him through those familiar partisan lenses, and low support among Republicans pulls down the president's overall numbers.
Obama's approval rating, for example, is 89 percent among Democrats and 25 percent among Republicans. Among independents, his approval rating is 58 percent.
Another reason that the president lost a little ground could be an uptick in pessimism about the economy.
The survey found 57 percent saying the worst is yet to come on the economy, up from 54 percent a month ago. Just 3 percent said they thought the economy had "turned the corner" toward better times, down from 7 percent.
Those with more to lose are more pessimistic: Among those who make more than $50,000 a year, 66 percent think that things will continue to get worse. Among those who earn less than that, 50 percent think that things will get worse.
There was, however, a marginal increase in the number of people who think that the country is headed in the right direction, from 42 percent to 44 percent.
Partisan differences also could be influencing that, as 62 percent of Democrats think that the country is headed in the right direction now, while just 20 percent of Republicans think so.
Fears grow Iraq violence will doom Obama's Afghan plan
Auto repair industry thriving in down economy
Has Edwards told wife he fathered baby? He didn't say, and no one asked


text:
This exciting show on solar science, created by the Michigan Science Center in collaboration with NASA and narrated by noted science fiction author Mike Shepherd, shares the wonders of our own personal star, the Sun. The Sun's incredible energy has supported life on Earth for millennia, but it also poses threats to the way of life our 21st century technology has enabled. In Sunstruck, you will travel to the distant future to discover the Sun's connection to our universe's cosmic cycle of life and death.
Recommended for ages 8 and up


text:
Email Disclaimer
The information in this e-mail or in any file attached hereto is intended only for the personal and confidential use of the individual or entity to which it is addressed and may contain information that is proprietary and confidential.
If you are not the intended recipient of this message you are hereby notified that any review, dissemination, distribution or copying of this message is strictly prohibited.
This communication is for information purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy any financial product. E-mail transmission cannot be guaranteed to be secure or error-free.


text: It's All Politics South's Tornado Tragedy Joins Political Foes For Now April 29, 2011 Natural disasters are no respecters of political parties or any of the other numerous ways humans use to separate themselves from each other. That seems to get largely ignored until calamities strike. Then, state officials who usually pan feds as intrusive welcome help from Washington.


text:
published at 18.11.2012 / created by Marcia Hill
Red Bull KTM Factory rider Taddy Blazusiak of Poland was crowned the 2012 AMA EnduroCross Championship after sweeping both mains in the Las Vegas double-header final held at the Orleans Arena on Saturday night.
Taddy Blazusiak turned the fastest lap in the afternoon hot laps to earn first gate pick in his heat. He was placed in the third heat where he took the holeshot and led every lap to easily transfer into the main event. His teammate, Factory FMF/KTM rider Mike Brown, finished 2nd in his heat to also earn a top gate pick in the first main event.
When the gate dropped for the first main event it was Blazusiak and Brown out front early. The KTM riders led the pack for the first two laps before Brown made a mistake and dropped to third. Then Blazusiak got stuck in the treacherous rocks section in the third lap letting Cody Webb rake the lead. The two riders swapped the lead for the next four laps but with two to go, Blazusiak pulled a small gap and took the win and having gone into the final competition needing only three more points to secure his 2012 AMA EnduroCross Championship, already had it in the bag. KTM teammate Mike Brown joined him on the podium with a third place finish.
Blazusiak shot off the start gate in the second main event to come around the first corner tied for the lead. He quickly moved his KTM out front and led the way around the first lap.
Out front, Blazusiak again had a bobble in the rocks that allowed Webb to close the gap. Webb did his best to challenge the champion but Blazusiak did not buckle and remained in the lead. The two riders proceeded to duke it out until the end, delivering a thrilling display of riding that had the crowd on the edge of their seats as the race came down to the final rock section. Blazusiak found a clear line and smoothly raced through the rocks to go on to win the second main event of the night. Brown was able to successfully climb from his poor start into the top five to finish fifth overall on the night and bumped him up into overall fourth in the championship.
"It was great to have Taddy return to defend his championship this year. We are happy he was able to clinch another championship. He and the team have worked very hard for this championship and it is a great ending to the year to take the number one plate again," stated Team Manager Antti Kallonen.
Speaking of KTM's Polish rider, EnduroCross promoter Eric Peronnard was quoted on the official EnduroCross website recently saying: "Taddy Blazusiak is without any question the best EnduroCross rider in the world."
Results Las Vegas Main Event 1
1. Taddy Blazusiak (PL), KTM
2. Cody Webb (USA), Beta
3. Mike Brown (USA), KTM
4. Geoff Aaron (USA), Honda
5. Justin Soule (USA), Kawasaki
Results Las Vegas Main Event 2
1. Blazusiak
2. Webb
3. Kyle Redmond (USA), Husqvarna
4. Aaron
5. Brown
Final Standings EnduroCross 2012
1. Blazusiak, 249 points (2012 EnduroCross Champion)
2. Webb, 179
3. Taylor Robert (USA), Kawasaki, 154
4. Brown, 151
5. Cory Graffunder (USA), Husqvarna, 133


text:
Sochi on view: Scenes from the Winter Games
The 2014 Winter Olympics are officially underway in Sochi, Russia. The country is hosting its first Winter Games, which are set to include a record 98 events, up from 86 during the 2010 games in Vancouver.
Over the course of the 2014 Winter Olympics, msnbc will bring you images from the competitions and glimpses of the spectacle surrounding the international event.
Check back daily to see the latest images from the Olympics.


text:
Janssen nearly cleared to throw again
ANAHEIM — Casey Janssen and Jeremy Accardo have a double date with Dr. Lewis Yocum here tonight. Janssen's hoping to get the go-ahead to begin throwing for the first time since season-ending surgery on his right shoulder in March. Accardo wants some peace of mind about his right forearm strain so he can breathe easier in bullpen sessions.
Janssen said today that he doesn't see why he wouldn't be cleared, considering how well his workouts have been going. Talked to pitching coach Brad Arnsberg, who caught Accardo in a long-toss session on Friday and said he doesn't think Accardo will need Tommy John surgery — the worst-case scenario.
In a perfect world, which this is not, Janssen will be cleared and on pace to fight for a job with the Jays next spring. Accardo will be told there's no ligament damage in his arm and he'll continue his program with the goal of getting back in the bullpen within the next few weeks. We'll know more later…
As for the ol' lineup, Jays skip Cito Gaston did some tweaking today, moving Mighty Joe Inglett into the leadoff spot and giving Brad Wilkerson the nod in left (Adam Lind is the DH). If the new top of the lineup produces some tonight, Gaston said maybe he'll stick with Inglett in the No. 1 hole for a while.
Today's lineups:
TORONTO (41-46) at LOS ANGELES (52-34)
at 9:05 p.m. ET at Angel Stadium
Joe Inglett, 2B
Marco Scutaro, SS
Alex Rios, RF
Vernon Wells, CF
Brad Wilkerson, LF
Scott Rolen, 3B
Lyle Overbay, 1B
Gregg Zaun, C
Adam Lind, DH
PITCHING: RHP Roy Halladay (9-6, 2.90)
Chone Figgins, 3B
Casey Kotchman, 1B
Maicer Izturis, SS
Vladimir Guerrero, RF
Torii Hunter, CF
Garret Anderson, DH
Gary Matthews Jr., LF
Howie Kendrick, 2B
Mike Napoli, C
PITCHING: RHP John Lackey (6-1, 1.44)
10 Comments
The Doc looks hot tonight maybe we can get lucky and win one tonight.
One thing for sure Cito and crew will not turn this team around this season but with luck maybe next year we can win 88 or 89 games and at least look like like we care they dont have to win the world series to make me happy just stay close.
Mighty Joe just never quits how lucky are we to have him also Lind.
Well Gsumner where are the sceptics now I mean the ones that told you Lind could not hit I guess they are hiding under their beds lol.
By the way where are Bosoxbrian and Indigo did they enlope LOL.
Last year Lind had a swing problem on high outer half pitches, in which he'd try to pull them from an open stance and hit soft ground balls or very weak flys to left field. He fixed that problem early in AAA this year by maintaining a closed stance and going with the pitch-which is the way he hit when he first came up in 2006 and hit .367.
The guy that fixed the problem was his old batting coach that he had in school. Early in the season Syracuse did an inteview with that coach, which I read, who explained the change. When Lind started in Syracuse, he confirmed that the fix worked when he hit .350+ and lead AAA in BA and RISP. That's why I was so pro Lind. I didn't expect he could hit .350+ here, but felt he could hit .300+ and more importantly drive in runs. None of the naysayers knew or cared about the swing fix. What I never understood is why he was sent back down, and we played has beens like Stewart, Mench and Wilkerson. I think Gibbons didn't like Lind, or there was a problem; something was definately wrong, because the Jays management KNEW how well he was doing in AAA. We were struggling and they didn't bring him back up. The real interesting thing, to me, was the moment Cito became manager, up came Lind.
Lind is the real deal, and will be one of our best clutch hitters for years. Once he really settles in, I'd expect he'll hit 20-30 HR's per year, hit .300+ and drive in 100+ if he's put higher up in the order.
I belive Cito will keep him down in the order until Sept or next year to give him a chance to gain confidencein himself at this level[Rios].
How about Rios tonight three stolen bases not to shaby.
Rios had a good game, maybe he's starting to finally heat up. Nice outing from Halliday.
Yes Doc pitched a good game,BJ had me on the edge of my chair I hate it when they bring in the closer when he's not pitchen for a save they don't pitch the same.
Any news on what Burnett is being traded for or any offers we might have recieved? There has gotta be some team interested in him?
I doubt Boston will trade Lowrie, they have a good enough rotation and they will need him at SS once lugo is gone.
Just read news that Bedard is rumored to be on the Trading Market?
who would take him?
I would and it woudl be so much better if he was still with Baltimore then would could give up burnett and eck for Bedard…oh well
what do you think its gonna take to get Bedard from the Mariners? I am sure they wouldn't want Burnett.
Harry Bedard will go for a high price lets give them Jessi the creep Esk and two prospects and JP. They want to cut the payroll so thet leaves burnett out,Myself I would try to trade him to Boston for Lowery,They might make that trade because every team thinks they have the anwser to Burnett.
No Boston has Clay Buckholz, Taylor Buckholz, Matsuzaka, Beckett, Justin Masterson, Tim Wakefeild (is Curth Schilling thinking of coming back?)…basically Boston has alot of young guys and the others are better than Burnett…
well if boston don't do the deal, Id try to trade him to Milwaukee for Gamel and Escobar who both play for their AA team, but solve our problem at ss and 3rd.


text:
Photo Contest: Spring. See Detail In: http://phoanh.vn/photo-contest-spring/
Album – Photo Contest: https://www.flickr.com/photos/phoanh/
It's a pleasure for our forum to invite all domestic and foreign photographers to take participation in the February 2018 competition with the topic of "Spring".
Topic: "Spring"
General rules:
– Candidates' photographs must be taken themselves, therefore unreal photos or copy from the others will be not accepted.
– Quantity: maximum 50 photos in JPEG format are allowed to send by each candidate.
– Image resolution: is 300dpi/inches
– Capacity: from 1MB to 10MB per file
– Please upload your photos on: https://www.facebook.com/groups/phoanh/ or email: firstname.lastname@example.com
– Deadline: 8.3.2018
Author: Lưu Minh Dân (Facebook Account)
– We are not responsible for the photo copywright.
– The fist stage: 8/2/2018
– Inform the winners publicly: 8.00 A.m, 8.3.2018
* Prizes include:
– First prize: 1.000.000 VND = (50 USD) + A Present 1 Holder Bombo100 + Adapter Ring 77mm (Price: 650.000 = (30 USD) VND) – Bombo Company and a medal.
– The second prize: Lens Nikon/Canon 18-55 ISII or Lens Nikon/Canon 50 F1.8
1. Bui Minh Son, E.VAPA / G, E.FIAP – Board Chairman of Ho Chi Minh Photographer Organization.
2. Hoang Thach Van, E.VAPA / G, E.FIAP – Vice Chairman of the HCM Photographer Organization. – Member.
3. Hoang Trung Thuy, VAPA – Board Chairman – Gia Dinh Photo.
4. Tran Cao Bao Long, A.VAPA / A.FIAP – Member.
5. Hoang The Nhiem, A.VAPA – Member
We hope photographers and those love photography paying attention to above rules we'd like all candidates do sincerely before entering for our February – 2018 Competition successfully.
Source: https://www.facebook.com/groups/phoanh/
Fanpage: https://www.facebook.com/phoanh.vn
Twitter: https://twitter.com/phoanhvn
G+: https://goo.gl/esigCg
Instagram: https://www.instagram.com/phoanh.vn
Partner: http://phoanh.vn/partner/


text:
Tabla Wala
Gift Certificates
Product 1/9
This product was added to our catalog on Wednesday 05 October, 2011.
EthnoSuperLounge is an independent artist-operated website. All proceeds go to the musicians. Thanks for your support. For more information, please visit the Record Company's webpage.
ESL Shop Home
My Account
Site Map
Privacy Notice


text:
Explore Our Hotel
Archdale, NC Hotel Near High Point University
The Holiday Inn Express® Hotel & Suites High Point South is ideally located on I-85 near High Point, NC. Our hotel's accommodations are 17 miles south of Greensboro and 25 minutes from Piedmont Triad International Airport (GSO).
We're a top spot for visitors buying home furnishings from local furniture stores and for those attending the famous High Point Market or shopping at the famous Furnitureland South.
If you're on business in the High Point - Archdale, NC area, our hotel has the quality amenities and convenient location you need. In addition, you can use the copy, fax and print services from our business center to help you prepare for any meetings.
If you're looking for hotels in High Point, NC near attractions like Castle McCulloch, look no further. We're only a few minutes from this destination, popular as a wedding venue and for gold panning.
Whether business or pleasure brings you to High Point, NC, our hotel's complimentary high-speed internet access keeps you connected, and our sparkling, outdoor pool is the perfect place to cool off. Stretch out in a larger suite, complete with microwave, mini fridge, mini sink with countertop, and living area. Enjoy a complimentary hot breakfast. If you forget anything, ask our friendly front desk staff for complimentary toiletries. Our convenient services and great prices make us standout among hotels in High Point, NC.
- Black-out Shades
- Rollaway Bed/Cot Available
- Crib Available
- Iron/Ironing Board
- Separate Hanging Closet
- In-Room Heating and A/C Controls
Bathroom/Personal Care
- Private Bathroom
- Bathroom Amenities Available
- Hair Dryer
- Bathtub
- Separate/Walk-in Shower
In-Room Features
- Mini Refrigerator
- Microwave
- Coffee Maker
- Flat-screen TV
- Work Desk with Lamp
- Desk-level Electrical Outlet
- Free Local Calls
- Cable/Satellite
- Premium Channels
- Direct-dial Phone
- Phone with Voicemail
- Complimentary Morning Newspaper
- Windows Open by Guest
Added Value
- Connecting Rooms Available
- Oversized Bath Towels
- Complimentary Coffee/Tea Supplies
- Complimentary Bottled Water
- Full Breakfast Included
- Breakfast Buffet Included
- Continental Breakfast Included
- Complimentary Coffee in Lobby
Business Services
- On-Site Business Center
- Printer
- Copier
- Office supplies available
Internet Access
- Free High-Speed Internet in all Rooms
- Wireless Internet service is free for all IHG® Rewards Club members
Entertainment & Recreation
- Outdoor Pool
- Outdoor Pool Hours of Operation: 10:00 AM - 9:00 PM
- Pool Open from: 21-May-2019 to 13-September-2019
Health & Fitness
1 Treadmill, 1 Elliptical, 1 Recumbent Stationary Bike, Free Weights, Excercise Ball, and Yoga Mat
Hours of Operation: 7:00 AM to 7:00 AM
Fitness Center Type: LIMITED
Fitness Center Equipment:
- Treadmill
- Elliptical Machines
- Free Weights
- Stationary Bicycle
Last Renovation of Fitness Center Equipment: 2016
Housekeeping & Laundry
- Daily Housekeeping
Added Value
- Wake Up Calls
- Storage Space Available
Hotel Details
10050 N. Main St
Archdale, North Carolina 27263
United States
Check In: 3:00 PM
Check Out: 12:00 PM
Check-in Age: 18
Parking + -
- Complimentary Self Parking Available
Accessibility + -
- Public Entrance
- Guest Rooms
- Elevators
- Public Restrooms
- Registration Desk
- Exercise Facility
- Business Center
- Pool
- Number of Accessible Meeting Rooms: 0
Accessible Hotel Areas
- Registration Area
- Accessible Guest Rooms
- Business Center
- Pool
Hotel Areas with Accessible Routes from Accessible Public Entrance
- Accessible Self Parking
- Van Accessible Self Parking
- Ramp Access
- Closed Caption TVs
- Telephone with TDD
- Visual Alarm/Alert in Guest Rooms
- Visual Alarm/Alert in Public Spaces
- Communication Kits with Visual Alarms
Provided by Hotel
Pet Policy + -
- Pets Allowed
- Service Animals Allowed
- Pet Walking Area On-site
- Pet Deposit per Stay: 50 USD
- Pets happily accepted with a 50 dollar pet fee per stay. Pet agreement reviewed at check in.
Facility + -
- Smoke-Free Facility
- Number of Floors: 3
- Total Number of Rooms: 70
- Number of Suites: 15
- Number of Non-Smoking Rooms: 70
- Number of Accessible Rooms: 6
- Connecting Rooms Available
- Public Spaces Renovated in: 2016
- Guest Rooms Renovated in: 2016
Languages + -
Languages Spoken by Staff
- English
- Spanish
Credit Cards + -
- American Express
- Visa
- MasterCard
- Diners Club
- Carte Blanche
- Discover